WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Lung Cancer efficacy endpoints v3, Karnofsky with allowed values 0, 10, 20...100, -cough -shortness of breath -chest pain -fatigue -other specifying severity, Sponsor specified Response Criteria (e.g. RECIST) has_component Follow-up evaluation, Therapeutic Efficacy Endpoint is intersection of Therapeutic Intervention, Short axis for target lymph nodes measured in mm, Non-target lesion summarized into OVERALL RESPONSE, Baseline assessment summarized_by Non-measurable lesions, Disease recurrence determined_by Tumor assessment, Objective Response Rate (ORR) measured at Defined Time Points, Defined Time Points include Date of tumor progression, Informational or proposed for removal concepts identified by grey color boxes, Time to progression of cancer symptoms includes Name of the PRO instrument, Duration of response include Date of tumor progression, LD (axial plane) for target lesion measured in mm, Non-target lesion have response options -Complete Response (CR) -Non-CR/non-PD -Not evaluated -Not all evaluated -Non-PD -PD -Unequivocal PD -Any, Sum of longest diameters (SLD) has_component LD (axial plane) for target lesion, Target lesion can_include Cystic lesion, Follow-up evaluation summarized_by Measurable lesions, Tumor assessment specifies Tumor Response, Concepts are denoted by solid round-edged rectangle